Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Early Treatment with Anti-VLA-4 mAb Can Prevent the Infiltration and/or Development of Pathogenic CD11b+CD4+ T Cells in the CNS during Progressive EAE.
Right Under Our Noses: Olfactory Pathology In Central Nervous System Demyelinating Diseases
Disease Suppression Persists With Ozanimod at 72 Weeks in MS
Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning.
Evaluation of a new approach for semi-automatic segmentation of the cerebellum in patients with multiple sclerosis.
HyperCKemia Related to the Initial and Recurrent Attacks of Neuromyelitis Optica.
Do not treat from CIS onset: evaluate disease course and prognosis first - No (treat!).
Conference Report: Multiple Sclerosis Update: Hot topics from 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS/ACTRIMS).
Keeping cool: use of air conditioning by australians with multiple sclerosis.
Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients.
The role of microbiome in central nervous system disorders.
Assessing the role of patient support services on adherence rates in patients using glatiramer acetate for relapsing-remitting multiple sclerosis.
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis.
Solitary sclerosis: progressive myelopathy from solitary demyelinating lesion. A new entity?
Newly diagnosed multiple sclerosis in state of Qatar.
MULTIPLE SCLEROSIS: MOLECULAR MECHANISMS AND THERAPEUTIC OPPORTUNITIES.
Stelara (Ustekinumab) receives FDA Approval for Treatment of Moderate to Severe Plaque Psoriasis with Four-Times-A-Year Maintenance Dosing
Endogeneous Remyelination: Findings in Human Studies.
Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology.
Including known covariates can reduce power to detect genetic effects in case-control studies.
Sleep-disordered breathing in multiple sclerosis.
Obstructive sleep apnea and fatigue in patients with multiple sclerosis.
[Epstein-Barr virus in the pathogenesis of multiple sclerosis (a review).]
Fingolimod for the Treatment of Intracerebral Hemorrhage: A 2-Arm Proof-of-Concept Study.
IgM antibody identifies good candidates for natalizumab

Pages